+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 5 Actively Recruiting clinical trials

C

Actively Recruiting

This trial investigates the comparative effectiveness of two beta-blocker drugs, carvedilol and metoprolol succinate, in adults with heart failure with reduced ejection fraction HFrEF who have an implantable cardioverter defibrillator ICD. The study aims to provide clear data on which medication better reduces the risk of ICD therapy, cardiovascular hospitalizations, or cardiovascular death. It is a prospective, multicenter, randomized clinical trial enrolling 2,000 participants across 100 U.S. sites, including an 18-month feasibility phase. Participants currently taking metoprolol succinate will be randomized to either continue this treatment or switch to carvedilol at an equivalent dose. Both groups will have their doses adjusted to the maximum tolerated level as per the study protocol. The feasibility phase will evaluate recruitment, safety, adherence, and retention, while the full study will follow participants for up to three years, assessing clinical outcomes and quality of life. During the study, participants will undergo regular assessments including ICD device checks, laboratory tests, imaging, and surveys on quality of life and anxiety related to ICD shocks. Data collected will include cardiovascular events, healthcare use, medication adherence, and patient-reported outcomes measured at baseline and throughout the follow-up. The trial will also analyze results by patient subgroups such as age, sex, race, heart failure type, and ICD type to better understand treatment responses.

Age: 18Years +All GendersPhase 4
13 locations
E

Actively Recruiting

Researchers are studying younger breast cancer survivors who experience elevated depressive symptoms to compare digital mindfulness meditation programs. This phase III clinical trial evaluates two digital methods a live instructor-led program over Zoom and a self-paced app-based program. The study aims to find which digital approach best improves mental health and well-being after completing primary cancer treatment. Participants are randomly assigned to one of three groups a live online mindfulness group meeting weekly for six weeks via Zoom a self-paced app-based mindfulness program with lessons and exercises unlocked sequentially or a meditation-only control group using guided audio meditations. All participants will have access to the mindfulness meditation app throughout the study, including six months of follow-up. Devices and internet access are provided to those who need them. During the study, participants will attend group sessions or use the app according to their assigned group and complete daily mindfulness practice. Researchers will track engagement and measure depressive symptoms at two weeks, three to six months, and six months after the intervention. They will also assess fatigue and explore factors influencing treatment effects and cost-effectiveness. The total study duration spans the six-week intervention plus six months of follow-up.

Age: 18Years - 50YearsAll GendersPhase 3
456 locations
P

Actively Recruiting

Researchers are evaluating the Integrity Implant System in adults with rotator cuff tears of the shoulder. This study aims to confirm the devices performance, safety, and clinical benefit when used to augment rotator cuff tears, with or without repair. The trial focuses on reducing rotator cuff re-tear rates and improving shoulder function through a prospective, multi-center, single-arm, non-randomized post-market clinical follow-up. Participants will receive the Integrity Implant System during rotator cuff tear surgery, which may involve mini-open or arthroscopic approaches. The study will follow patients for up to 24 months after surgery, assessing repair integrity with MRI at 12 months and monitoring other functional outcomes and safety throughout the study period. During the study, participants will complete questionnaires measuring shoulder function, pain, and quality of life at screening, 6 weeks, 6 months, 12 months, and 24 months post-surgery. MRI scans will evaluate tendon repair quality and tissue regeneration. Safety will be tracked by recording adverse events. Participants need to follow rehabilitation instructions and attend all follow-up visits to support comprehensive evaluation of the implants performance.

Age: 18Years +All GendersPhase Not Applicable
9 locations
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
S

Actively Recruiting

Researchers are evaluating the use of the REGENETEN14 Bioinductive Implant system compared to the standard surgical technique called Completion and Repair for treating patients with high-grade partial-thickness rotator cuff tears. The goal is to see if the implant allows patients to return to their daily activities faster and to assess functional recovery at three months after treatment. Participants will undergo surgical repair of their rotator cuff tear using either the REGENETEN Bioinductive Implant Isolated Bioinductive Repair or the standard Completion and Repair method. The study is randomized with two parallel groups comparing these two surgical approaches for partial-thickness tears greater than 50% or 6 mm in size. Throughout the study, participants will be followed up with assessments including shoulder function scores, pain levels, MRI imaging, patient satisfaction, and time to return to work, driving, and sports. These evaluations occur before surgery and at multiple intervals up to 24 months. Researchers will also monitor surgery details, opioid use, physical therapy use, and any revision surgeries, aiming to measure shoulder function improvement primarily at three months after surgery.

Age: 18Years +All GendersPhase Not Applicable
20 locations